- Home
- XGN vs RFM Comparison
XGN vs RFM Comparison
Compare XGN & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XGN | RFM |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.5M | 89.6M |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | XGN | RFM |
|---|---|---|
| Price | $3.59 | $14.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 354.2K | 30.5K |
| Earning Date | 04-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.99 | N/A |
| Revenue Next Year | $11.27 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.80 | $13.14 |
| 52 Week High | $12.23 | $15.46 |
Technical Indicators
Market Signals| Indicator | XGN | RFM |
|---|---|---|
| Relative Strength Index (RSI) | 42.42 | 55.26 |
| Support Level | $3.15 | $14.24 |
| Resistance Level | $4.00 | $14.90 |
| Average True Range (ATR) | 0.27 | 0.22 |
| MACD | 0.11 | -0.02 |
| Stochastic Oscillator | 55.29 | 57.75 |
Price Performance
Historical ComparisonAbout XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.